Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Leukemia, Myeloid, Acute 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Myelodysplastic Syndromes 15Hematologic Neoplasms 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Lymphoma, Non-Hodgkin 6Neuroblastoma 5Leukemia, Biphenotypic, Acute 5Myeloproliferative Disorders 4Graft vs Host Disease 4Multiple Myeloma 3Medulloblastoma 3Lymphoma, Large B-Cell, Diffuse 3Leukemia 3Hodgkin Disease 3Ganglioneuroblastoma 3Blastic Plasmacytoid Dendritic Cell Neoplasm 3Lymphoma 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Myelomonocytic, Chronic 2Anemia, Refractory, with Excess of Blasts 2Teratoma 1Sarcoma, Myeloid 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Recurrence 1Pyloric Stenosis, Hypertrophic 1Pinealoma 1Neurofibrosarcoma 1

Interventions

Vincristine 13Temozolomide 12Cyclophosphamide 11Irinotecan 8Magnetic Resonance Spectroscopy 7X-Rays 6Vinorelbine 6Specimen Handling 6Phantoms, Imaging 6Dactinomycin 6Biopsy 5fludarabine 4Radiotherapy 4Radiation 4Nuclear Medicine Department, Hospital 4Filgrastim 4Etoposide 4pegfilgrastim 3irinotecan sucrosofate 3Sirolimus 3Proton Therapy 3Melphalan 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rhabdomyosarcoma × Thiotepa × 1 year × Clear all
NCT04530487 2025-06-29

Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults

M.D. Anderson Cancer Center

Phase 2 Terminated
1 enrolled 7 charts
CNSSarcoma

Neuroblastoma, Rhabdomyosarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Neurofibrosarcoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡